CJC-1295 with DAC synergetics-peptides modified with a Drug Affinity

modified with a Drug Affinity Complex (DAC) to extend its half-life in laboratory settings

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding peptide found in human plasma and other bodily fluids

and tumour biology

Our Kisspeptin peptide is produced to high purity and supplied strictly for laboratory research use only

CJC-1295 with DAC synergetics-peptides modified with a Drug AffinityCJC 1295 with DAC is a synthetic peptide based on growth hormone releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) to extend its half life in laboratory settings. This modification allows it to bind to serum proteins, resulting in prolonged activity during scientific studies. In research environments, CJC 1295 with DAC has been studied for its potential to influence growth hormone secretion and IGF 1 levels, both of which are